← Back to Bills
HR 9098118th CongressFailed / ExpiredHouse

Peggy Lillis Clostridioides difficile Inclusion Act

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Nov 12, 2024
Latest Action Date
Jul 23, 2024

Latest Action

Referred to the House Committee on Energy and Commerce.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Peggy Lillis Clostridioides difficile Inclusion Act is a health-related bill introduced in the 118th Congress. The bill was referred to the House Committee on Energy and Commerce but has no publicly available summary or full text. It is related to Clostridioides difficile, a bacterial infection, and presumably aims to address issues related to this infection, though specific provisions are not provided. The bill status is marked as Failed / Expired, indicating it did not advance to become law during the session.

Bottom Line

This health-focused bill concerning Clostridioides difficile was introduced but did not progress beyond committee referral and ultimately expired without enactment.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill is titled the Peggy Lillis Clostridioides difficile Inclusion Act and pertains to health policy.
  • It was introduced in the House of Representatives during the 118th Congress and referred to the House Committee on Energy and Commerce.
  • No official summary or full text is publicly available, limiting detailed analysis of its provisions or intended impact.
Who Benefits?

['Patients affected by Clostridioides difficile infections', 'Healthcare providers and public health agencies involved in infection control', 'Health policy and research organizations focused on infectious diseases']

Potential Concerns

['Lack of publicly available full text and summary limits understanding of implementation requirements and costs', 'Unclear authority or enforcement mechanisms due to missing bill details', 'Potential oversight challenges given the absence of detailed provisions']

Political Context

The bill was introduced in the House and referred to the Energy and Commerce Committee, a common venue for health-related legislation. Its failure to advance suggests it did not receive sufficient legislative support or priority during the 118th Congress. The absence of a summary or full text in public records limits insight into its legislative intent or debate context.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

['Potential increased focus on Clostridioides difficile infection awareness and research if similar future legislation is introduced', "Possible influence on healthcare policy discussions related to infectious disease control despite this bill's failure", 'Limited direct impact due to bill expiration, but may inform future legislative efforts']

GovScope Watchdog Notes

The absence of an official summary and full bill text significantly limits transparency and public understanding of the bill's intent and provisions. This lack of documentation hinders effective oversight and informed debate. The bill's failure to advance further reduces immediate policy impact but highlights the importance of accessible legislative information for government transparency.

Passage Likelihood: LowConfidence: 60%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready